Newsroom

Sorted by: Latest

-

New Study Finds Restart of V.C. Summer Project Will Support 10,000 South Carolina Jobs

COLUMBIA, S.C.--(BUSINESS WIRE)--Westinghouse Electric Company released a comprehensive, independent report from PricewaterhouseCoopers LLC (PwC) detailing the substantial economic impact of completing the two partially built AP1000® advanced modular reactors at V.C. Summer Nuclear Station in Jenkinsville, South Carolina. The study found that the construction phase of the V.C. Summer project can create more than $7.3 billion of gross domestic product (GDP) for the state, while supporting 7,300...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 08.12.2025 FPX. IE00BYTH6238 225,002.00 USD 14,082,788.28 62.590  ...
-

Levelpath Extends AI Procurement Platform with Invoice Automation to Protect Financial Accuracy and Capture Negotiated Savings From Receipt to Payment

SAN FRANCISCO--(BUSINESS WIRE)--Levelpath extends AI procurement platform with Invoice Automation to protect financial accuracy and capture negotiated savings from receipt to payment...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 08.12.2025 GINC LN IE00BD842Y21 711,004.00 USD 40,451,570.88 56.894  ...
-

Broadwood Partners Responds to Alcon’s Increase to Proposed Acquisition Price of STAAR Surgical

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood,” “we,” “us” or “our”) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) by Alcon Inc. (“Alcon”) (NYSE: ALC). Broadwood, which owns 30.2% of STAAR’s outstanding common stock, continues to oppose the proposed sale of the Company to Alcon and issued the following statement: “STAAR spent months trying to conv...
-

fal Raises $140M in Series D Led by Sequoia, with Major Participation from Kleiner Perkins and New Investment from Alkeon Capital and NVentures (NVIDIA’s venture capital arm) to Accelerate the Future of Real-Time Generative Media

SAN FRANCISCO--(BUSINESS WIRE)--fal, the real-time generative-media platform powering the next decade of AI-driven content, today announced a $140 million Series D financing. The round is led by Sequoia, with significant participation from Kleiner Perkins and new investment from NVentures, NVIDIA’s venture capital arm, and Alkeon Capital. The round also includes continued support from existing investors Andreessen Horowitz (a16z), Kindred Ventures, Meritech, Bessemer Venture Partners, Notable C...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 08.12.2025 FGOV LN IE00BKS2X200 33,638.00 GBP 499,066.67 16.990  ...
-

Theraclion Announces Sonovein FDA Submission Following a Strong Year of Regulatory and Clinical Achievements

MALAKOFF, France--(BUSINESS WIRE)--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose vein treatment, reports today the key regulatory and clinical communication achievements of the past year across congresses, publications, and expert presentations. Regulatory update: FDA submission Theraclion announces that the full dataset from the U.S. Food and Drug...
-

THERACLION ANNONCE LA SOUMISSION SONOVEIN À LA FDA APRÈS UNE ANNÉE DE PROGRÈS RÉGLEMENTAIRES ET CLINIQUES

MALAKOFF, France--(BUSINESS WIRE)--THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour la thérapie non invasive par ultrasons focalisés de haute intensité (HIFU) pour le traitement des varices, le Sonovein®, présente aujourd’hui les principaux résultats réglementaires et cliniques de l’année écoulée, issus des congrès, des publications scientifiques et des interventions d’experts. Mise à jour réglementaire : soumission à la FDA Theraclion a...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 08.12.2025 IPXE.IM IE00BFD26097 75,002.00 EUR 1,693,831.06 22.584  ...